Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients With Multiple SclerosisImpact of Fingolimod Therapy in Multiple Sclerosis.
[Pharmacological properties and clinical efficacy of fingolimod hydrochloride (Imusera®/Gilenya®) for the treatment of multiple sclerosis].
Myelination of the nervous system: mechanisms and functions.
The role of growth factors as a therapeutic approach to demyelinating disease.
Cyclophosphamide for multiple sclerosis.
Mutations affecting segment number and polarity in Drosophila.
Amiloride Hydrochlorothiazide as Treatment of Acute Inflammation of the Optic Nerve
Safety, tolerability, and efficacy of orally administered cannabinoids in MS.
Emerging tumefactive MS after switching therapy from interferon-beta to fingolimod: A case report.
Elevated Expression of the Cerebrospinal Fluid Disease Markers Chromogranin A and Clusterin in Astrocytes of Multiple Sclerosis White Matter Lesions.
Patients with MS under daclizumab therapy mount normal immune responses to influenza vaccination.
Four Square Step Test in ambulant persons with multiple sclerosis: validity, reliability, and responsiveness.
Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO.
Zebrafish screen identifies novel compound with selective toxicity against leukemia.
A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Longitudinally extensive transverse myelitis with anti-NMDA receptor antibodies during a systemic lupus erythematosus flare-up.
Patients feeling severely affected by multiple sclerosis: How do patients want to communicate about end-of-life issues?
Quantitative MRI and Cerebrospinal Fluid Inflammatory Mediators in Brazilian Patients with Relapsing-Remitting Multiple Sclerosis before and after Treatment with Immunomodulators: A Longitudinal Study.
The olfactory vector hypothesis of neurodegenerative disease: is it viable?
SMAD family proteins: the current knowledge on their expression and potential role in neoplastic diseases.
The natural course of clinically isolated syndrome in pediatric patients.
The initiation and prevention of multiple sclerosis.
miRNA in multiple sclerosis: search for novel biomarkers.
Noninvasive molecular imaging of neuroinflammation.
Challenges and recommendations for obtaining chemical structures of industry-provided repurposing candidates.

Pages